{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:47:09Z","timestamp":1775890029868,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/inf.0b013e3181b20ebd","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T08:21:54Z","timestamp":1261642914000},"page":"65-67","source":"Crossref","is-referenced-by-count":20,"title":["Itraconazole Treatment of Nonmeningeal Coccidioidomycosis in Children"],"prefix":"10.1097","volume":"29","author":[{"given":"James D.","family":"Homans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaShonda","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210202","first-page":"2580","article-title":"Textbook of Pediatric Infectious Diseases.","author":"Shehab","year":"2004"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1196\/annals.1406.000","article-title":"State-of-the-art treatment of coccidioidomycosis skeletal infections.","volume":"1111","author":"Blair","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-133-9-200011070-00009","article-title":"Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.","volume":"133","author":"Galgiani","year":"2000","journal-title":"Ann Intern Med"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0733-8635(03)00030-5","article-title":"Efficacy and safety of itraconazole use in children.","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/AAC.45.5.1561-1564.2001","article-title":"Pharmacokinetics of itraconazole oral solution in neutropenic children during long-term prophylaxis.","volume":"45","author":"Schmitt","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00006454-200012000-00018","article-title":"Fluconazole treatment of coccidioidal meningitis in children: two case reports and a review of the literature.","volume":"19","author":"Saitoh","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann Intern Med"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1345\/aph.1L005","article-title":"Posaconazole: an oral triazole with an extended spectrum of activity.","volume":"42","author":"Rachwalski","year":"2008","journal-title":"Ann Pharmacother"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1086\/424019","article-title":"Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole.","volume":"39","author":"Prabhu","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/375235","article-title":"Successful treatment of coccidioidal meningitis with voriconazole.","volume":"36","author":"Cortez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14656566.1.2.287","article-title":"Itraconazole.","volume":"1","author":"Pierard","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"R12-19-20210202","first-page":"387","article-title":"Itraconazole: pharmacokinetics and indications.","volume":"24","author":"Negroni","year":"1993","journal-title":"Arch Med Res"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.100.3.682","article-title":"Itraconazole in the treatment of coccidioidomycosis.","volume":"100","author":"Diaz","year":"1991","journal-title":"Chest"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0002-9343(90)90339-F","article-title":"Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group.","volume":"89","author":"Graybill","year":"1990","journal-title":"Am J Med"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2710.2001.00338.x","article-title":"Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.","volume":"26","author":"Willems","year":"2001","journal-title":"J Clin Pharm Ther"},{"issue":"suppl 1","key":"R16-19-20210202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-200161001-00003","article-title":"Pharmacology of itraconazole.","volume":"61","author":"de Beule","year":"2001","journal-title":"Drugs"},{"key":"R17-19-20210202","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/AAC.44.6.1512-1517.2000","article-title":"Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.","volume":"44","author":"Sorensen","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-112-2-108","article-title":"Itraconazole therapy for chronic coccidioidal meningitis.","volume":"112","author":"Tucker","year":"1990","journal-title":"Ann Intern Med"},{"key":"R19-19-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/14.1.165","article-title":"Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.","volume":"14","author":"Tucker","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"R20-19-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0507.2008.01523.x","article-title":"Antifungal agents\u2013clinical pharmacokinetics and drug interactions.","volume":"51","author":"Lipp","year":"2008","journal-title":"Mycoses"},{"key":"R21-19-20210202","first-page":"4","article-title":"FDA Consum.","volume":"35","year":"2001","journal-title":""},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(00)04891-1","article-title":"Congestive heart failure associated with itraconazole.","volume":"357","author":"Ahmad","year":"2001","journal-title":"Lancet"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201001000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:05:40Z","timestamp":1618279540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201001000-00019"}},"subtitle":["Two Case Reports and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181b20ebd","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}